According to a report on CNBC-TV18, an EIR has been issued to the company’s Duvvada facility. The report further states that Duvvada facility status continues to be classified as official action initiated.
In pharmaceuticals parlance, OAI means a regulatory and / or admin sanctions by the drug regulator are initiated.
The channel also reported that 13 US FDA observation details were given to the unit in February-March 2017.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory